RVMDHealthcareLarge-Cap
Revolution Medicines, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Revolution Medicines, Inc. (RVMD), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are RVMD insiders buying or selling?
Revolution Medicines, Inc. insiders reported 11 open-market buys ($134.5M) and 220 sells ($367.4M) across 231 Form 4 filings — a net selling position of $232.9M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jul 1, 2026)
Total Form 4 filings
231
SEC EDGAR
Insider filers
19
Insider buys (11)
$134.5M
Insider sells (220)
$367.4M
Insider sentiment
Net sellingNet insider flow of $232.9M in net selling.
Recent RVMD insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | Sushil Patel | Director | Sale | 5.6K | $187.99 | $1.0M |
| Jun 26, 2026 | Jack Anders | Chief Financial Officer | Sale | 20.0K | $168.33 | $3.4M |
| Jun 18, 2026 | Anthony Mancini | Chief Global Commercialization Officer | Sale | 4.6K | $156.12 | $720.5K |
| Jun 18, 2026 | Mark A Goldsmith | President and Chief Executive Officer | Sale | 10.0K | $156.12 | $1.6M |
| Jun 18, 2026 | Jeff Cislini | General Counsel | Sale | 2.2K | $156.12 | $336.7K |
| Jun 18, 2026 | Jack Anders | Chief Financial Officer | Sale | 2.7K | $156.12 | $425.0K |
| Jun 18, 2026 | Stephen Michael Kelsey | President, Research and Development | Sale | 4.2K | $156.12 | $651.8K |
| Jun 17, 2026 | Margaret A Horn | Chief Operating Officer | Sale | 93.6K | $160.00 | $15.0M |
| Jun 15, 2026 | Margaret A Horn | Chief Operating Officer | Sale | 10.0K | $148.01 | $1.5M |
| May 28, 2026 | Anthony Mancini | Chief Global Commercialization Officer | Sale | 3.1K | $153.99 | $480.6K |
| Apr 29, 2026 | Anthony Mancini | Chief Global Commercialization Officer | Sale | 3.1K | $132.41 | $413.1K |
| Apr 17, 2026 | Mark A Goldsmith | President and Chief Executive Officer | Sale | 120.0K | $150.09 | $18.0M |
| Mar 27, 2026 | Anthony Mancini | Chief Global Commercialization Officer | Sale | 37.5K | $95.56 | $3.6M |
| Mar 19, 2026 | Lin Wei | Chief Medical Officer | Sale | 2.1K | $99.48 | $206.2K |
| Mar 19, 2026 | Stephen Michael Kelsey | President, Research and Development | Sale | 4.3K | $99.48 | $428.0K |
| Mar 19, 2026 | Mark A Goldsmith | President and Chief Executive Officer | Sale | 12.9K | $99.48 | $1.3M |
| Mar 19, 2026 | Margaret A Horn | Chief Operating Officer | Sale | 4.6K | $99.48 | $455.9K |
| Mar 19, 2026 | Jack Anders | Chief Financial Officer | Sale | 2.8K | $99.48 | $273.9K |
| Mar 19, 2026 | Jeff Cislini | General Counsel | Sale | 3.0K | $98.68 | $291.9K |
| Mar 19, 2026 | Xiaolin Wang | EVP, Clinical Development | Sale | 2.0K | $99.48 | $200.0K |
| Mar 4, 2026 | Mark A Goldsmith | President and Chief Executive Officer | Sale | 36.0K | $101.23 | $3.6M |
| Jan 23, 2026 | Jeff Cislini | General Counsel | Sale | 908 | $115.60 | $105.0K |
| Jan 9, 2026 | Margaret A Horn | Chief Operating Officer | Sale | 75.0K | $100.56 | $7.5M |
| Jan 9, 2026 | Jack Anders | Chief Financial Officer | Sale | 10.0K | $98.00 | $980.0K |
| Dec 18, 2025 | Jeff Cislini | General Counsel | Sale | 2.7K | $76.82 | $206.5K |
Showing the 25 most recent of 231 Form 4 filings for Revolution Medicines, Inc..
Most active RVMD insiders
- Mark A Goldsmith42 filings
- Stephen Michael Kelsey41 filings
- Margaret A Horn34 filings
- Jeff Cislini31 filings
- Jack Anders30 filings
Ask anything about RVMD insider activity
Use Trabud's AI agent to query Revolution Medicines, Inc.'s Form 4 history in plain English — "Show me RVMD CEO purchases this year" or compare it against any other ticker.
Open the AI agentRVMD insider trading FAQ
Are Revolution Medicines, Inc. insiders buying or selling?
Across 231 SEC Form 4 filings, Revolution Medicines, Inc. (RVMD) insiders reported 11 open-market purchases totaling $134.5M and 220 sales totaling $367.4M. That is a net selling position of $232.9M.
How many insiders trade RVMD stock?
19 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Revolution Medicines, Inc.. The most recent filing was accepted on Jul 1, 2026.
Where does Trabud get RVMD insider trading data?
All RVMD insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.